pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
News | Timely industry updates for pharma and biotech leaders
3 天之前 · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
1 天前 · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth …
Deep-Dive | pharmaphorum
2024年11月25日 · Dear Readers, The 2024 US election has cast a long shadow over the pharma industry, with the policies of the next administration poised to reshape drug development, …
pharmaphorum - The Deep Dive Digital Magazine has fresh …
2024年2月28日 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, …
Pharma in the age of acceleration - pharmaphorum
That’s not to say that they have to rigidly adhere to the way pharma works, but there’s certainly a need for a highly collaborative approach and the generation of data that people will believe, …
Pills and polls: What the 2024 election means for pharma
President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per-month out-of …
Building a strong pharma brand - pharmaphorum
This is when companies need to capture and listen to real-time feedback and this needs to go beyond simple sales numbers. To really understand how the product is being received, ‘softer’ …
Views & Analysis | Perspectives on pharma industry issues
2 天之前 · Diverse and engaging perspectives on pharma developments and debates from pharmaphorum editors, industry insiders, and contributing experts.
Pharma | pharmaphorum
Unlocking impact and growth at times of demerger. Pharma and medtech companies have undergone unprecedented growth through aggressive M&A over the